CIK 0001628908
- Large accelerated filer
Evolent Health, Inc.
Sign in to watch- Ticker
- EVH
- Exchange
- NYSE
- Industry
- Services-Management Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320454912
- Phone
- +1 571-389-6000
- Business address
- 1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $329,460
- in 1 filing, $329K under 10b5-1 plans
Net −$329,460. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion | +6,000 | $3.84 | $23K | 18,411 |
| 2017-08-01 | WIGGINTON STEVE CEO, Valence Health | Sale | −6,000 | $24.64 | $148K | 12,411 |
| 2017-08-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion · Class A Common Stock Option (right to buy) | −6,000 | 399,680 | ||
| 2017-07-03 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion | +6,000 | $3.84 | $23K | 18,411 |
| 2017-07-03 | WIGGINTON STEVE CEO, Valence Health | Sale | −6,000 | $25.07 | $150K | 12,411 |
| 2017-07-03 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion · Class A Common Stock Option (right to buy) | −6,000 | 405,680 | ||
| 2017-06-06 | WIGGINTON STEVE CEO, Valence Health | Sale | −959 | $25.75 | $25K | 12,411 |
| 2017-06-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion | +6,000 | $3.84 | $23K | 19,370 |
| 2017-06-01 | WIGGINTON STEVE CEO, Valence Health | Sale | −1,600 | $23.51 | $38K | 17,770 |
| 2017-06-01 | WIGGINTON STEVE CEO, Valence Health | Sale | −4,400 | $24.36 | $107K | 13,370 |
| 2017-06-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion · Class A Common Stock Option (right to buy) | −6,000 | 411,680 | ||
| 2017-05-19 | WIGGINTON STEVE CEO, Valence Health | Sale | −13,640 | $24.30 | $331K | 13,370 |
| 2017-05-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion | +6,000 | $3.84 | $23K | 364,704 |
| 2017-05-01 | WIGGINTON STEVE CEO, Valence Health | Sale | −6,000 | $23.10 | $139K | 358,704 |
| 2017-05-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion · Class A Common Stock Option (right to buy) | −6,000 | 417,680 | ||
| 2017-04-03 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion | +6,000 | $3.84 | $23K | 364,704 |
| 2017-04-03 | WIGGINTON STEVE CEO, Valence Health | Sale | −5,300 | $23.11 | $122K | 359,404 |
| 2017-04-03 | WIGGINTON STEVE CEO, Valence Health | Sale | −700 | $23.41 | $16K | 358,704 |
| 2017-04-03 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion · Class A Common Stock Option (right to buy) | −6,000 | 423,680 | ||
| 2017-03-03 | WIGGINTON STEVE CEO, Valence Health | Sale | −988 | $20.20 | $20K | 358,704 |
Page 1 of 2 · 30 trades